Russ Altman is the Kenneth Fong Professor of Bioengineering, Genetics, Medicine, Biomedical Data Science and (by courtesy) Computer Science at Stanford University. His primary research interests are in the application of computing to problems relevant to medicine. Kim Branson is a senior vice president and Global Head of Artificial Intelligence and Machine Learning at GSK, where he leads the GSK.ai team, a group of nearly 100 machine learning researchers and engineers who are pioneering the application of AI to drug discovery and development. In this conversation with Stanford adjunct lecturer and STVP Director of Principled Entrepreneurship Jack Fuchs, Altman and Branson discuss how ethics and principles can shape innovation at the intersection of AI and drug development.
Related
Sam Altman,
OpenAI
The Possibilities of AI [Entire Talk]
AI opportunities are just beginning. The future holds risks and rewards.
Video
46 minutes
Sam Altman,
OpenAI
The Possibilities of AI [Entire Talk]
AI opportunities are just beginning. The future holds risks and rewards.
Qasar Younis,
Applied Intuition
Radically Pragmatic Insights [Entire Talk]
Becoming a successful entrepreneur requires more than ambition.
Video
45 minutes
Qasar Younis,
Applied Intuition
Radically Pragmatic Insights [Entire Talk]
Becoming a successful entrepreneur requires more than ambition.
Sharon Prince,
Grace Farms Foundation
Designing From Values [Entire Talk]
A space is an expression of values, from the earliest concepts to the actual materials.
Video
51 minutes
Sharon Prince,
Grace Farms Foundation
Designing From Values [Entire Talk]
A space is an expression of values, from the earliest concepts to the actual materials.